Low Risk Myelodysplastic Syndromes Completed Phase 1 Trials for SLN124 (DB18646)

Also known as: Low Risk Myelodysplastic Syndrome / Low-risk Myelodysplastic Syndrome

IndicationStatusPhase
DBCOND0147387 (Low Risk Myelodysplastic Syndromes)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04718844A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic SyndromeTreatment